Enliven Therapeutics, Inc.
ELVN
37 insider filings · Latest: Oct 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 9 8:12 PM | Collins Helen Louise | Proposed Sale | 45,000 | $29.44 | $1.3M | — | View → |
| Mar 6, 2026 | Mar 6 9:06 PM | Hohl Benjamin | Proposed Sale | 10,000 | $29.29 | $292.9K | — | View → |
| Feb 17, 2026 | Feb 19 11:38 PM | Richard A. HeymanDirector | Sale | 1,230 | $26.18 | $32.2K | 22,647(I) | View → |
| Feb 17, 2026 | Feb 19 11:36 PM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Sale | 45,000 | $26.17 | $1.2M | 25,000(D) | View → |
| Feb 18, 2026 | Feb 18 9:25 PM | Lyssikatos Joseph P | Proposed Sale | 75,000 | $26.13 | $2.0M | — | View → |
| Feb 17, 2026 | Feb 17 9:50 PM | Kintz Samuel | Proposed Sale | 75,000 | $26.72 | $2.0M | — | View → |
| Feb 17, 2026 | Feb 17 9:44 PM | Heyman Richard A. | Proposed Sale | 1,230 | $26.72 | $32.9K | — | View → |
| Feb 17, 2026 | Feb 17 9:40 PM | Collins Helen Louise | Proposed Sale | 45,000 | $26.72 | $1.2M | — | View → |
| Feb 6, 2026 | Feb 10 11:12 PM | Joseph P LyssikatosCHIEF SCIENTIFIC OFFICER | Sale | 5,000 | $29.04 | $145.2K | 740,188(I) | View → |
| Feb 2, 2026 | Feb 2 10:38 PM | ANDREW PHILLIPS | Proposed Sale | 21,844 | $28.00 | $611.7K | — | View → |
| Jan 20, 2026 | Jan 22 10:34 PM | Joseph P LyssikatosCHIEF SCIENTIFIC OFFICER | Sale | 20,000 | $26.75 | $535.1K | 745,188(I) | View → |
| Jan 20, 2026 | Jan 22 10:33 PM | Richard A. HeymanDirector | Sale | 1,230 | $26.75 | $32.9K | 23,877(I) | View → |
| Jan 20, 2026 | Jan 20 9:55 PM | Heyman Richard A. | Proposed Sale | 1,230 | $26.71 | $32.9K | — | View → |
| Jan 9, 2026 | Jan 9 9:50 PM | Lyssikatos Joseph P | Proposed Sale | 75,000 | $23.25 | $1.7M | — | View → |
| Jan 9, 2026 | Jan 9 9:49 PM | Kintz Samuel | Proposed Sale | 75,000 | $23.25 | $1.7M | — | View → |
| Jan 9, 2026 | Jan 9 9:18 PM | Patel Anish | Proposed Sale | 48,300 | $23.25 | $1.1M | — | View → |
| Jan 8, 2026 | Jan 8 9:42 PM | Kintz Samuel | Proposed Sale | 82,500 | $15.47 | $1.3M | — | View → |
| Jan 8, 2026 | Jan 8 9:26 PM | Lyssikatos Joseph P | Proposed Sale | 82,500 | $15.47 | $1.3M | — | View → |
| Jan 8, 2026 | Jan 8 9:26 PM | Heyman Richard A. | Proposed Sale | 1,620 | $15.47 | $25.1K | — | View → |
| Jan 8, 2026 | Jan 8 9:18 PM | Heyman Richard A. | Proposed Sale | 12,300 | $15.47 | $190.3K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Feb 18 12:57 AM | Scott J. GarlandDirector | Grant/Award | 1,427 | $27.16 | 1,427(D) | View → |
| Feb 12, 2026 | Feb 18 12:56 AM | Mika K DerynckDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:56 AM | Jake BauerDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:55 AM | Rahul D. BallalDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:53 AM | Anish PatelCHIEF OPERATING OFFICER | Grant/Award | 120,000 | $27.16 | 120,000(D) | View → |
| Feb 12, 2026 | Feb 18 12:52 AM | Joseph P LyssikatosCHIEF SCIENTIFIC OFFICER | Grant/Award | 112,500 | $27.16 | 112,500(D) | View → |
| Feb 12, 2026 | Feb 18 12:49 AM | Benjamin HohlCHIEF FINANCIAL OFFICER | Grant/Award | 150,000 | $27.16 | 150,000(D) | View → |
| Feb 12, 2026 | Feb 18 12:47 AM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Grant/Award | 150,000 | $27.16 | 150,000(D) | View → |
← Previous
Page 2 of 2